News Releases

<< Back
Waters Corporation to Host Press Conference at PITTCON 2005; Corporation to Detail Real-World Applications for Its Breakthrough UPLC Technology

ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 25, 2005--Waters Corporation will host a press conference Monday, February 28th from 8:30 - 9:30 a.m. in Room N220C at The Orange County Convention Center, Orlando, Florida in conjunction with The Pittsburgh Conference (PITTCON(R) 2005), the largest annual exposition and technical conference on laboratory science. At the press conference, Waters(R) will provide an update on the impact that UPLC(TM) is having on laboratory productivity and discuss new product introductions for its ACQUITY UPLC(TM) product line including an evaporative light scattering detector, new ACQUITY UPLC chemistries and an LC/MS - based proteomics solution powered by ACQUITY UPLC technology. In addition, the corporation will also unveil a new version of its flagship Empower(TM) Software. The company is exhibiting in booths 1369 and 1855.

For more information about PITTCON 2005, go to

About Waters Corporation

Waters Corporation holds worldwide leading positions in three complementary analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis. These market segments account for $4.5 - $5.0 billion of the overall $20+ billion analytical instrumentation market.

Waters is a registered trademark and UPLC, Empower and ACQUITY UPLC are trademarks of Waters Corporation. PITTCON is a registered trademark of The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy.

Certain statements contained herein are forward looking. Many factors could cause actual results to differ from these statements, including delays in product introductions, loss of market share through competition, introduction of competing products by other companies, pressures on prices from competitors and/or customers, regulatory obstacles to new product introductions, lack of acceptance of new products, changes in the healthcare market and the pharmaceutical industry, changes in distribution of the Company's products, and foreign exchange fluctuations. Such factors are discussed in detail in the Company's filings with the Securities and Exchange Commission and, in particular, the Company's Annual Report on Form 10-K for the year ended December 31, 2003.

Waters Corporation
Brian Murphy, 508-482-2614
Corporate Communications